PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
209 hedge funds and large institutions have $2.41B invested in Portola Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 74 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more funds holding
Funds holding: 181 → 209 (+28)
67% less call options, than puts
Call options by funds: $8.72M | Put options by funds: $26M
Holders
209
Holding in Top 10
8
Calls
$8.72M
Puts
$26M
Top Buyers
| 1 | +$53.6M | |
| 2 | +$42.4M | |
| 3 | +$32.6M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$20M |
| 5 |
JPMorgan Chase & Co
New York
|
+$17.4M |
Top Sellers
| 1 | -$86.3M | |
| 2 | -$75.8M | |
| 3 | -$30.9M | |
| 4 |
Citigroup
New York
|
-$19.2M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$16.9M |